Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Gorelick

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Archives of Neurology|March 1, 1992
Personality changes in Alzheimer's diseaseF G Bózzola, P B Gorelick, S Freels
Clinical Neuropharmacology|August 1, 1992
The role of drugs in the etiology of strokeM A Kelly, P B Gorelick, D Mirza
Neurology|July 23, 1998
Calcific cerebral embolism in systemic calciphylaxisG Katsamakis, T G Lukovits, P B Gorelick
Neurology|April 2, 1999
Stroke prevention trials: how many enrollees can be expected by site?T G Lukovits, K Thomas, P B Gorelick
Archives of Neurology|August 1, 1981
Enhanced ptosis in myasthenia gravisP B Gorelick, M Rosenberg, R J Pagano
Headache|March 17, 2001
Should you screen for an aneurysm in a migraineur whose mother died from a ruptured intracranial saccular aneurysm?R W Evans, P B Gorelick, D Rothbart
Stroke|July 1, 1986
Race, sex and occlusive cerebrovascular disease: a reviewL R Caplan, P B Gorelick, D B Hier
Seminars in Neurology|June 1, 1987
Drug therapy for ischemic strokeP B Gorelick, D B Hier, M J Swiontoniowski
Neurology|October 26, 1999
Risk factors and their management for stroke prevention: outlook for 1999 and beyondR L Sacco, P A Wolf, P B Gorelick
Journal of the National Medical Association|October 1, 1996
Why African Americans may not be participating in clinical trialsY Harris, P B Gorelick, P Samuels, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Archives of Neurology|March 1, 1992
Personality changes in Alzheimer's diseaseF G Bózzola, P B Gorelick, S Freels
Clinical Neuropharmacology|August 1, 1992
The role of drugs in the etiology of strokeM A Kelly, P B Gorelick, D Mirza
Neurology|July 23, 1998
Calcific cerebral embolism in systemic calciphylaxisG Katsamakis, T G Lukovits, P B Gorelick
Neurology|April 2, 1999
Stroke prevention trials: how many enrollees can be expected by site?T G Lukovits, K Thomas, P B Gorelick
Archives of Neurology|August 1, 1981
Enhanced ptosis in myasthenia gravisP B Gorelick, M Rosenberg, R J Pagano
Headache|March 17, 2001
Should you screen for an aneurysm in a migraineur whose mother died from a ruptured intracranial saccular aneurysm?R W Evans, P B Gorelick, D Rothbart
Stroke|July 1, 1986
Race, sex and occlusive cerebrovascular disease: a reviewL R Caplan, P B Gorelick, D B Hier
Seminars in Neurology|June 1, 1987
Drug therapy for ischemic strokeP B Gorelick, D B Hier, M J Swiontoniowski
Neurology|October 26, 1999
Risk factors and their management for stroke prevention: outlook for 1999 and beyondR L Sacco, P A Wolf, P B Gorelick
Journal of the National Medical Association|October 1, 1996
Why African Americans may not be participating in clinical trialsY Harris, P B Gorelick, P Samuels, et al.
Pageof 13